The Latin America, Middle East and Africa Digital Therapeutics Market would witness market growth of 22.8% CAGR during the forecast period (2021-2027). There is an increasing demand for digital therapeutics across the globe, due to the rising adoption of smartphones & tablets along with healthcare apps, increasing cases of chronic diseases, and the growing need to manage healthcare costs.
Moreover, high growth opportunities in the undiscovered markets are anticipated to offer new growth avenues for the manufacturers operating in the digital therapeutics market. Though, the absence of awareness related to digital therapeutics in emerging nations and the increasing concern about patient data is hampering the growth of the market. There is a rising awareness among the general public due to the consistently evolving digital landscape.
Moreover, factors like increasing cases of chronic diseases across the world and the increasing technological developments are also contributing to the growth of the market. With the rising awareness among end-users due to the adoption of various digital gadgets and solutions, the demand for digital therapeutics is anticipated to surge the market growth in the coming years. It is expected that people will maintain this inclination towards digital health space, which will spur the demand for customized, more engaging, and accessible medical solutions. Consumers are increasingly using smartphones and the internet that also acts as a major factor contributing to the growth of the market.
The Patients market dominated the UAE Digital Therapeutics Market by End Use 2020, thereby, achieving a market value of $64.1 million by 2027, growing at a CAGR of 20.8 % during the forecast period. The Providers market is experiencing a CAGR of 21.7% during (2021 - 2027). Additionally, The Payers market is expected to witness highest CAGR of 22.9% during (2021 - 2027).
Based on End Use, the market is segmented into Patients, Providers, Payers, Employers and Others. Based on Applications, the market is segmented into Diabetes, CNS Disease, Respiratory Diseases, Smoking Cessation, Obesity, CVD and others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Digital Therapeutics Market is Predict to reach $14.5 Billion by 2027, at a CAGR of 21.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ResMed, Inc. (Propeller Health), Teladoc Health, Inc. (Livongo Health), Noom, Inc., Omada Health, Inc., Welldoc, Inc., Canary Health, Mango Health, Inc. (TrialCard, Incorporated), 2Morrow, Inc., Pear Therapeutics, Inc., and Mindstrong, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End Use
- Patients
- Providers
- Payers
- Employers
- Others
By Application
- Diabetes
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Obesity
- CVD
- others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- ResMed, Inc. (Propeller Health)
- Teladoc Health, Inc. (Livongo Health)
- Noom, Inc.
- Omada Health, Inc.
- Welldoc, Inc.
- Canary Health
- Mango Health, Inc. (TrialCard, Incorporated)
- 2Morrow, Inc.
- Pear Therapeutics, Inc.
- Mindstrong, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Digital Therapeutics Market, by End Use
1.4.2 LAMEA Digital Therapeutics Market, by Application
1.4.3 LAMEA Digital Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Restraints:
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Business Expansions
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Mar – 2021, Mar) Leading Players
Chapter 4. LAMEA Digital Therapeutics Market by End Use
4.1 LAMEA Patients Market by Country
4.2 LAMEA Providers Market by Country
4.3 LAMEA Payers Market by Country
4.4 LAMEA Employers Market by Country
4.5 LAMEA Other End Use Market by Country
Chapter 5. LAMEA Digital Therapeutics Market by Applications
5.1 LAMEA Diabetes Applications Market by Country
5.2 LAMEA CNS Disease Applications Market by Country
5.3 LAMEA Respiratory Diseases Applications Market by Country
5.4 LAMEA Smoking Cessation Applications Market by Country
5.5 LAMEA Obesity Applications Market by Country
5.6 LAMEA CVD Applications Market by Country
5.7 LAMEA Other Applications Market by Country
Chapter 6. LAMEA Digital Therapeutics Market by Country
6.1 Brazil Digital Therapeutics Market
6.1.1 Brazil Digital Therapeutics Market by End Use
6.1.2 Brazil Digital Therapeutics Market by Applications
6.2 Argentina Digital Therapeutics Market
6.2.1 Argentina Digital Therapeutics Market by End Use
6.2.2 Argentina Digital Therapeutics Market by Applications
6.3 UAE Digital Therapeutics Market
6.3.1 UAE Digital Therapeutics Market by End Use
6.3.2 UAE Digital Therapeutics Market by Applications
6.4 Saudi Arabia Digital Therapeutics Market
6.4.1 Saudi Arabia Digital Therapeutics Market by End Use
6.4.2 Saudi Arabia Digital Therapeutics Market by Applications
6.5 South Africa Digital Therapeutics Market
6.5.1 South Africa Digital Therapeutics Market by End Use
6.5.2 South Africa Digital Therapeutics Market by Applications
6.6 Nigeria Digital Therapeutics Market
6.6.1 Nigeria Digital Therapeutics Market by End Use
6.6.2 Nigeria Digital Therapeutics Market by Applications
6.7 Rest of LAMEA Digital Therapeutics Market
6.7.1 Rest of LAMEA Digital Therapeutics Market by End Use
6.7.2 Rest of LAMEA Digital Therapeutics Market by Applications
Chapter 7. Company Profiles
7.1 ResMed, Inc. (Propeller Health)
7.1.1 Company Overview
7.1.1 Financial Analysis
7.1.2 Segmental and Regional Analysis
7.1.3 Research & Development Expense
7.1.4 Recent strategies and developments:
7.1.4.1 Approvals and Trials:
7.1.4.2 Partnerships, Collaborations, and Agreements:
7.2 Teladoc Health, Inc. (Livongo Health)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Recent strategies and developments:
7.2.3.1 Partnerships, Collaborations, and Agreements:
7.2.3.2 Acquisition and Mergers:
7.3 Noom, Inc.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations, and Agreements:
7.4 Omada Health, Inc.
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Partnerships, Collaborations, and Agreements:
7.4.2.2 Acquisition and Mergers:
7.4.2.3 Product Launches and Product Expansions:
7.5 Welldoc, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Canary Health
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Partnerships, Collaborations, and Agreements:
7.6.2.2 Business Expansions:
7.7 Mango Health, Inc. (TrialCard, Incorporated)
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Partnerships, Collaborations, and Agreements:
7.8 2Morrow, Inc.
7.8.1 Company Overview
7.9 Pear Therapeutics, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Acquisition and Mergers:
7.9.2.3 Product Launches and Product Expansions:
7.10. Mindstrong, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
TABLE 1 LAMEA Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 2 LAMEA Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Digital Therapeutics Market
TABLE 4 Product Launches And Product Expansions– Digital Therapeutics Market
TABLE 5 Business Expansions– Digital Therapeutics Market
TABLE 6 Acquisition and Mergers– Digital Therapeutics Market
TABLE 7 LAMEA Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 8 LAMEA Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 9 LAMEA Patients Market by Country, 2017 - 2020, USD Million
TABLE 10 LAMEA Patients Market by Country, 2021 - 2027, USD Million
TABLE 11 LAMEA Providers Market by Country, 2017 - 2020, USD Million
TABLE 12 LAMEA Providers Market by Country, 2021 - 2027, USD Million
TABLE 13 LAMEA Payers Market by Country, 2017 - 2020, USD Million
TABLE 14 LAMEA Payers Market by Country, 2021 - 2027, USD Million
TABLE 15 LAMEA Employers Market by Country, 2017 - 2020, USD Million
TABLE 16 LAMEA Employers Market by Country, 2021 - 2027, USD Million
TABLE 17 LAMEA Other End Use Market by Country, 2017 - 2020, USD Million
TABLE 18 LAMEA Other End Use Market by Country, 2021 - 2027, USD Million
TABLE 19 LAMEA Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 20 LAMEA Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 21 LAMEA Diabetes Applications Market by Country, 2017 - 2020, USD Million
TABLE 22 LAMEA Diabetes Applications Market by Country, 2021 - 2027, USD Million
TABLE 23 LAMEA CNS Disease Applications Market by Country, 2017 - 2020, USD Million
TABLE 24 LAMEA CNS Disease Applications Market by Country, 2021 - 2027, USD Million
TABLE 25 LAMEA Respiratory Diseases Applications Market by Country, 2017 - 2020, USD Million
TABLE 26 LAMEA Respiratory Diseases Applications Market by Country, 2021 - 2027, USD Million
TABLE 27 LAMEA Smoking Cessation Applications Market by Country, 2017 - 2020, USD Million
TABLE 28 LAMEA Smoking Cessation Applications Market by Country, 2021 - 2027, USD Million
TABLE 29 LAMEA Obesity Applications Market by Country, 2017 - 2020, USD Million
TABLE 30 LAMEA Obesity Applications Market by Country, 2021 - 2027, USD Million
TABLE 31 LAMEA CVD Applications Market by Country, 2017 - 2020, USD Million
TABLE 32 LAMEA CVD Applications Market by Country, 2021 - 2027, USD Million
TABLE 33 LAMEA Other Applications Market by Country, 2017 - 2020, USD Million
TABLE 34 LAMEA Other Applications Market by Country, 2021 - 2027, USD Million
TABLE 35 LAMEA Digital Therapeutics Market by Country, 2017 - 2020, USD Million
TABLE 36 LAMEA Digital Therapeutics Market by Country, 2021 - 2027, USD Million
TABLE 37 Brazil Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 38 Brazil Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 39 Brazil Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 40 Brazil Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 41 Brazil Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 42 Brazil Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 43 Argentina Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 44 Argentina Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 45 Argentina Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 46 Argentina Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 47 Argentina Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 48 Argentina Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 49 UAE Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 50 UAE Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 51 UAE Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 52 UAE Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 53 UAE Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 54 UAE Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 55 Saudi Arabia Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 56 Saudi Arabia Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 57 Saudi Arabia Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 58 Saudi Arabia Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 59 Saudi Arabia Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 60 Saudi Arabia Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 61 South Africa Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 62 South Africa Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 63 South Africa Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 64 South Africa Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 65 South Africa Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 66 South Africa Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 67 Nigeria Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 68 Nigeria Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 69 Nigeria Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 70 Nigeria Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 71 Nigeria Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 72 Nigeria Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 73 Rest of LAMEA Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 74 Rest of LAMEA Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 75 Rest of LAMEA Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 76 Rest of LAMEA Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 77 Rest of LAMEA Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 78 Rest of LAMEA Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 79 Key Information – ResMed, Inc.
TABLE 80 Key Information – Teladoc Health, Inc.
TABLE 81 key information – Noom, Inc.
TABLE 82 Key Information – Omada Health, Inc.
TABLE 83 key Information – Welldoc, Inc.
TABLE 84 Key Information – Canary Health
TABLE 85 key information – Mango Health, Inc.
TABLE 86 Key Information – 2Morrow, Inc.
TABLE 87 Key Information – Pear Therapeutics, Inc.
TABLE 88 Key Information – Mindstrong, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Mar – 2021, Mar) Leading Players
FIG 5 Recent strategies and developments: Teladoc Health, Inc.
FIG 6 Recent strategies and developments: Omada Health, Inc.
FIG 7 Recent strategies and developments: Canary Health
FIG 8 Recent strategies and developments: Pear Therapeutics, Inc.